These findings also identify the oncogenic roles of YTHDF3 as an m6A reader and highlight the therapeutic potential of targeting the ZDHHC20–YTHDF3–MYC signaling axis in pancreatic cancer. This evidence concerns the gene MYC and pancreatic neoplasm.